CLINICAL_TRIALS
trial_result
· 2023-09-15
Clinical Trial Update: Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial update showing results for a combination of anti-GITR and anti-PD1 therapy with stereotactic radiosurgery in recurrent glioblastoma; results poste…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pennsylvania | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-09-15